179 related articles for article (PubMed ID: 35251346)
21. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
22. Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
Li A; Eshaghpour A; Tseng EK; Douketis JD; Anvari M; Tiboni M; Siegal DM; Ikesaka RT; Crowther MA
Thromb Res; 2021 Feb; 198():1-6. PubMed ID: 33246191
[TBL] [Abstract][Full Text] [Related]
23. Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.
Friedel HA; Balfour JA
Drugs; 1994 Oct; 48(4):638-60. PubMed ID: 7528134
[TBL] [Abstract][Full Text] [Related]
24. Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Tsoukalas N; Papakotoulas P; Christopoulou A; Ardavanis A; Koumakis G; Papandreou C; Papatsimpas G; Papakostas P; Samelis G; Andreadis C; Aravantinos G; Ziras N; Kalofonos C; Samantas E; Souggleri M; Makrantonakis P; Pentheroudakis G; Athanasiadis A; Stergiou H; Tripodaki ES; Bokas A; Grivas A; Timotheadou E; Bournakis E; Varthalitis I; Boukovinas I
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679747
[No Abstract] [Full Text] [Related]
25. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
26. [Monitoring of tinzaparin in a ten day treatment dose in elderly patients].
Pautas E; Siguret V; d'Urso M; Laurent M; Gaussem P; Février M; Durand-Gasselin B
Rev Med Interne; 2001 Feb; 22(2):120-6. PubMed ID: 11234669
[TBL] [Abstract][Full Text] [Related]
27. Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial.
Rodger MA; Ramsay T; MacKinnon M; Westphal M; Wells PS; McCormick B; Knoll G
Am J Kidney Dis; 2012 Sep; 60(3):427-34. PubMed ID: 22480794
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the age-dependent dosing recommendations for the administration of daily tinzaparin in children with thrombosis.
Musgrave KM; Webber K; Murphy P; Avery P; Biss TT
J Thromb Haemost; 2017 Dec; 15(12):2361-2366. PubMed ID: 28976613
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin in healthy volunteers.
Fossler MJ; Barrett JS; Hainer JW; Riddle JG; Ostergaard P; van der Elst E; Sprogel P
Am J Health Syst Pharm; 2001 Sep; 58(17):1614-21. PubMed ID: 11556655
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.
Muñoz-Rivas N; Aibar J; Gabara-Xancó C; Trueba-Vicente Á; Urbelz-Pérez A; Gómez-Del Olmo V; Demelo-Rodríguez P; Rivera-Gallego A; Bosch-Nicolau P; Perez-Pinar M; Rios-Prego M; Madridano-Cobo O; Ramos-Alonso L; Alonso-Carrillo J; Francisco-Albelsa I; Martí-Saez E; Maestre-Peiró A; Méndez-Bailón M; Hernández-Rivas JÁ; Torres-Macho J;
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233500
[TBL] [Abstract][Full Text] [Related]
31. Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.
Hainer JW; Sherrard DJ; Swan SK; Barrett JS; Assaid CA; Fossler MJ; Cox DS; Williams RM; Pittenger AL; Stephenson CA; Hua TA
Am J Kidney Dis; 2002 Sep; 40(3):531-8. PubMed ID: 12200805
[TBL] [Abstract][Full Text] [Related]
32. Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study.
Frere C; Crichi B; Rueda-Camino JA; Cajfinger F; Spiess N; Janus N; Le Maignan C; Marjanovic Z; Farge D
J Med Vasc; 2022 Apr; 47(2):56-64. PubMed ID: 35691664
[TBL] [Abstract][Full Text] [Related]
33. Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study - The SeVEN EXTension study.
Karathanos C; Chatzis D; Latzios P; Papakostas I; Goumas K; Giannoukas AD;
Phlebology; 2021 Jul; 36(6):423-431. PubMed ID: 33407054
[TBL] [Abstract][Full Text] [Related]
34. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
35. Orally administered heparins prevent arterial thrombosis in a rat model.
Pinel C; Wice SM; Hiebert LM
Thromb Haemost; 2004 May; 91(5):919-26. PubMed ID: 15116252
[TBL] [Abstract][Full Text] [Related]
36. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
Hull RD; Pineo GF; Brant R; Liang J; Cook R; Solymoss S; Poon MC; Raskob G;
Am J Med; 2009 Aug; 122(8):762-769.e3. PubMed ID: 19635277
[TBL] [Abstract][Full Text] [Related]
37. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers.
Holst J; Lindblad B; Bergqvist D; Garre K; Nielsen H; Hedner U; Ostergaard PB
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):795-803. PubMed ID: 7865687
[TBL] [Abstract][Full Text] [Related]
38. Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile.
Nelson-Piercy C; Powrie R; Borg JY; Rodger M; Talbot DJ; Stinson J; Greer IA
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):293-9. PubMed ID: 21945573
[TBL] [Abstract][Full Text] [Related]
39. Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.
Lassen MR; Borris LC; Jensen HP; Poulsen KA; Ejstrud P; Andersen BS
Clin Appl Thromb Hemost; 2000 Jan; 6(1):53-7. PubMed ID: 10726050
[TBL] [Abstract][Full Text] [Related]
40. Tinzaparin sodium: a low-molecular-weight heparin.
Neely JL; Carlson SS; Lenhart SE
Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
